TFA
DICE

Toth Financial Advisory’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Toth Financial Advisory’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-50
Closed -$1.43K – 913
2023
Q1 		$1.43K Buy
+50
New +$1.48K ﹤0.01% 713

Other funds holding DICE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Toth Financial Advisory's DICE Position: Q2 2023 in Review

Toth Financial Advisory sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q2 2023, closing a stake of 50 shares — an estimated $1.43K sold.

Toth Financial Advisory first reported a position in DICE in Q1 2023 and held it in 1 quarter. The position peaked at $1.43K in Q1 2023. 160 funds tracked by Wall St. Rank hold DICE as of Q2 2023.

  • Toth Financial Advisory reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Toth Financial Advisory sold 50 DICE Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $1.43K.
  • Toth Financial Advisory first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Toth Financial Advisory's DICE Therapeutics, Inc. Common Stock position peaked at $1.43K in Q1 2023.
  • 160 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Toth Financial Advisory's 13F filing for Q2 2023, filed 24 Jul 2023.